novorapid flexpen insulin aspart (rys) 300u/3ml injection multidose cartridge
novo nordisk pharmaceuticals pty ltd - insulin aspart, quantity: 100 u/ml - injection, solution - excipient ingredients: phenol; sodium chloride; sodium hydroxide; water for injections; hydrochloric acid; zinc; metacresol; dibasic sodium phosphate dihydrate; glycerol - treatment of diabetes mellitus.
novorapid penfill insulin aspart (rys) 300u/3ml injection cartridge
novo nordisk pharmaceuticals pty ltd - insulin aspart, quantity: 100 u/ml - injection, solution - excipient ingredients: phenol; zinc; dibasic sodium phosphate dihydrate; sodium hydroxide; glycerol; metacresol; sodium chloride; water for injections; hydrochloric acid - treatment of diabetes mellitus.
novorapid insulin aspart (rys) 100u/ml injection multidose vial
novo nordisk pharmaceuticals pty ltd - insulin aspart, quantity: 100 u/ml - injection, solution - excipient ingredients: water for injections; metacresol; glycerol; sodium chloride; dibasic sodium phosphate dihydrate; hydrochloric acid; sodium hydroxide; zinc; phenol - treatment of diabetes mellitus.
novomix 30 flexpen
novo nordisk pharmaceuticals ltd - insulin aspart 100 iu/ml; - suspension for injection - 100 iu/ml - active: insulin aspart 100 iu/ml excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol protamine sulfate sodium chloride sodium hydroxide water for injection zinc as chloride - the treatment of diabetes mellitus
novorapid
novo nordisk pharmaceuticals ltd - insulin aspart 100 u/ml; - solution for injection - 100 u/ml - active: insulin aspart 100 u/ml excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol sodium chloride sodium hydroxide water for injection zinc as the chloride - the treatment of diabetes mellitus.
novorapid flexpen
novo nordisk pharmaceuticals ltd - insulin aspart 100 iu/ml; - solution for injection - 100 iu/ml - active: insulin aspart 100 iu/ml excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol sodium chloride sodium hydroxide water for injection zinc as chloride - the treatment of diabetes mellitus
novorapid penfill
novo nordisk pharmaceuticals ltd - insulin aspart 100 u/ml; - solution for injection - 100 u/ml - active: insulin aspart 100 u/ml excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol sodium chloride sodium hydroxide water for injection zinc as the choloride - the treatment of diabetes mellitus.
novomix 30 penfill 3ml 30% soluble insulin aspart (rys) and 70% insulin aspart (rys) crystallised with protamine 300u/3ml injection cartridge
novo nordisk pharmaceuticals pty ltd - insulin aspart, quantity: 100 u/ml - injection, suspension - excipient ingredients: zinc; dibasic sodium phosphate dihydrate; protamine sulfate; metacresol; sodium chloride; sodium hydroxide; glycerol; phenol; hydrochloric acid; water for injections - treatment of diabetes mellitus.
novomix 30 flexpen 3ml 30% soluble insulin aspart (rys) and 70% insulin aspart (rys) crystallised with protamine 300u/3ml injection syringe
novo nordisk pharmaceuticals pty ltd - insulin aspart, quantity: 100 u/ml - injection, suspension - excipient ingredients: hydrochloric acid; zinc; metacresol; water for injections; glycerol; sodium chloride; protamine sulfate; sodium hydroxide; dibasic sodium phosphate dihydrate; phenol - treatment of diabetes mellitus.
albumin (human)- albumin human solution
octapharma usa inc - albumin human (unii: zif514rvzr) (albumin human - unii:zif514rvzr) - albumin (human) 200 g in 1000 ml - albumin (human) 20% is indicated in the emergency treatment of hypovolemia with or without shock. its effectiveness in reversing hypovolemia depends largely upon its ability to draw interstitial fluid into the circulation. it is most effective in patients who are well hydrated. when blood volume deficit is the result of hemorrhage, compatible red blood cells or whole blood should be administered as quickly as possible. [ 1 , 2 ] when hypovolemia is long standing and hypoalbuminemia exists accompanied by adequate hydration or edema, 20% - 25% albumin solutions should be used. [ 1 ] for subjects with hypoalbuminemia who are critically ill and/or are bleeding actively, albumin (human) 20% infusions may be indicated. [ 3 ] when albumin deficit is the result of excessive protein loss, the effect of administration of albumin (human) 20% will be temporary unless the underlying disorder is reversed. albumin (human) 20% may be used to maintain cardiovascular function following the removal of large volumes of ascitic f